Thomas A. Keuer's most recent trade in Oruka Therapeutics Inc. was a trade of 40,000 Common Stock done . Disclosure was reported to the exchange on Dec. 8, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oruka Therapeutics Inc. | Thomas A. Keuer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 40,000 | 40,730 (2%) | 2% | 0 | Common Stock | |
Oruka Therapeutics Inc. | Thomas A. Keuer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
Oruka Therapeutics Inc. | Thomas A. Keuer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 70,000 | 70,000 | - | - | Stock Option (right to buy) |